Licensing

Building speciality pharma franchises

In parallel with product development, InterPharm builds stand-alone subsidiary companies focussed on specialist therapeutic areas. This strategy allows InterPharm to sell not only its own products, but also compatible products licensed in from third parties as finished products. InterPharm’s first affiliate is InterAlia srl, an oral healthcare franchise in Italy. InterAlia srl launched its first two products in 2011: Hali Z for improved oral hygiene, and Remesense for dental sensitivity. For more information, click here to visit the InterAlia website.

If you have licensing opportunities available for Italy and other EU countries either in oral healthcare or as a full product portfolio for other specialist areas, please contact us.

News

21-11-2011

InterPharm Investments appoints Financial Advisor to Board of Directors

10-10-2011

Remesense: A second product for InterPharm’s affilate, InterAlia srl

13-09-2011

Beata Brozek joins management teams at InterPharm Investments Ltd & InterAlia srl

30-06-2011

InterPharm Investments appoints Salvatore Barbagallo to Executive Committee

31-05-2011

InterPharm Investments appoints Chairman

06-05-11

InterPharm Investments Ltd acquires a strategic stake in InterAlia srl